- Home
- AQST vs ACTG Comparison
AQST vs ACTG Comparison
Compare AQST & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- ACTG
- Stock Information
- Founded
- AQST 2004
- ACTG 1993
- Country
- AQST United States
- ACTG United States
- Employees
- AQST N/A
- ACTG N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- ACTG Multi-Sector Companies
- Sector
- AQST Health Care
- ACTG Miscellaneous
- Exchange
- AQST Nasdaq
- ACTG Nasdaq
- Market Cap
- AQST 254.1M
- ACTG 289.2M
- IPO Year
- AQST 2018
- ACTG 1996
- Fundamental
- Price
- AQST $2.79
- ACTG $3.77
- Analyst Decision
- AQST Strong Buy
- ACTG
- Analyst Count
- AQST 5
- ACTG 0
- Target Price
- AQST $11.40
- ACTG N/A
- AVG Volume (30 Days)
- AQST 939.1K
- ACTG 285.6K
- Earning Date
- AQST 05-12-2025
- ACTG 05-08-2025
- Dividend Yield
- AQST N/A
- ACTG N/A
- EPS Growth
- AQST N/A
- ACTG N/A
- EPS
- AQST N/A
- ACTG N/A
- Revenue
- AQST $57,561,000.00
- ACTG $222,414,000.00
- Revenue This Year
- AQST N/A
- ACTG $86.80
- Revenue Next Year
- AQST $39.51
- ACTG N/A
- P/E Ratio
- AQST N/A
- ACTG N/A
- Revenue Growth
- AQST 13.79
- ACTG 65.22
- 52 Week Low
- AQST $2.20
- ACTG $2.70
- 52 Week High
- AQST $5.80
- ACTG $5.74
- Technical
- Relative Strength Index (RSI)
- AQST 49.93
- ACTG 72.30
- Support Level
- AQST $2.59
- ACTG $2.99
- Resistance Level
- AQST $3.05
- ACTG $3.21
- Average True Range (ATR)
- AQST 0.16
- ACTG 0.14
- MACD
- AQST 0.00
- ACTG 0.09
- Stochastic Oscillator
- AQST 43.57
- ACTG 94.57
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.